MET Share Price | MetLife, Inc. Stock Analysis & Recommendation

Q: Is MetLife, Inc. overvalued or undervalued?

As of 4 August 2025, the valuation grade for MetLife, Inc. moved from expensive to fair. The company appears fairly valued based on its current metrics. Key ratios include a P/E ratio of 18, a Price to Book Value of 2.94, and an impressive PEG Ratio of 0.18, indicating potential for growth relative to its price.In comparison to peers, MetLife's P/E ratio of 18.69 is slightly lower than Progressive Corp.'s 18.83, while The Travelers Cos., Inc. stands out with a much higher P/E of 40.11, suggesting that MetLife may offer better value at its current price point. Notably, over the past three years, MetLife has returned 21.50%, which is significantly lower than the S&P 500's 70.41% return, indicating that while the stock is fairly valued, it has lagged behind broader market performance.

Q: Is MetLife, Inc. technically bullish or bearish?

As of 9 September 2025, the technical trend for MetLife, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. The Bollinger Bands show a mildly bullish stance on the monthly chart, which supports the overall bullish trend. However, daily moving averages are mildly bearish, suggesting short-term weakness. The KST is bullish weekly but mildly bearish monthly, and the Dow Theory indicates a mildly bearish weekly trend but a mildly bullish monthly trend. In terms of performance, MetLife has underperformed the S&P 500 in the year-to-date and one-year periods, with returns of -3.43% and -0.23% compared to the S&P 500's 12.22% and 17.14%, respectively. However, over the three-year period, MetLife has returned 21.50%, outperforming the S&P 500's 70.41%. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands.

Q: How big is MetLife, Inc.?

As of Jun 18, MetLife, Inc. has a market capitalization of 78,851.05 million, categorizing it as a Large Cap company.As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, while the consolidated net profit for the same period was 4,519.00 million.As of Dec 24, the reporting period shows shareholder's funds of 27,445.00 million and total assets amounting to 677,457.00 million.

Q: What does MetLife, Inc. do?

Overview:MetLife, Inc. is a provider of life insurance, annuities, employee benefits, and asset management, operating within the insurance industry and classified as a large-cap company.Financial Snapshot:Most recent Net Profit: 950 Million (Quarterly Results - Mar 2025) Market Cap: USD 78,851.05 Million (Large Cap)Key Metrics:P/E: 18.00 Dividend Yield: 210.06% Debt Equity: -999,999.00 Return on Equity: 16.38% Price to Book: 2.87Contact Details:Address: 200 Park Ave, NEW YORK NY: 10166-0005 Tel: 1 212 5785500 Website: https://www.metlife.com/

Q: Who are in the management team of MetLife, Inc.?

As of March 2022, the management team of MetLife, Inc. includes the following individuals:- Dr. Robert Hubbard, who serves as the Independent Chairman of the Board.- Mr. Michel Khalaf, who is the President, Chief Executive Officer, and Director.- Ms. Cheryl Grise, who is an Independent Director.- Mr. Carlos Gutierrez, who is also an Independent Director.- Mr. Gerald Hassell, another Independent Director.- Mr. David Herzog, serving as an Independent Director.- Mr. Edward Kelly, who is an Independent Director as well.This team plays a crucial role in guiding the company's strategic direction and governance.

Results Declared: MetLife, Inc. has declared results on 05 Aug 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.27 M

Shareholding (Jun 2026)

FII

16.38%

Held by 438 FIIs

DII

83.61%

Held by 94 DIIs

Promoter

0.01%

Is MetLife, Inc. overvalued or undervalued?

20-Sep-2025

As of August 4, 2025, MetLife, Inc. is fairly valued with a P/E ratio of 18, a Price to Book Value of 2.94, and a PEG Ratio of 0.18, indicating potential growth, although it has underperformed the S&P 500 over the past three years with a return of 21.50%.

View full answer

Is MetLife, Inc. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, MetLife, Inc. shows a mildly bullish technical trend, supported by a bullish weekly MACD and Bollinger Bands, despite mixed signals from other indicators and underperformance compared to the S&P 500 in the short term.

View full answer

How big is MetLife, Inc.?

22-Jun-2025

As of Jun 18, MetLife, Inc. has a market capitalization of $78.85 billion, with total assets of $677.46 billion and a consolidated net profit of $4.52 billion for the latest four quarters.

View full answer

What does MetLife, Inc. do?

22-Jun-2025

MetLife, Inc. is a large-cap provider of life insurance, annuities, employee benefits, and asset management. As of March 2025, it reported a net profit of $950 million and has a market cap of approximately $78.85 billion.

View full answer

Who are in the management team of MetLife, Inc.?

22-Jun-2025

As of March 2022, MetLife, Inc.'s management team includes Dr. Robert Hubbard (Independent Chairman), Mr. Michel Khalaf (President and CEO), and several Independent Directors: Ms. Cheryl Grise, Mr. Carlos Gutierrez, Mr. Gerald Hassell, Mr. David Herzog, and Mr. Edward Kelly. They are responsible for the company's strategic direction and governance.

View full answer

Compare MetLife, Inc. with Similar Stocks

Progressive Corp.Aflac, Inc.American International Group, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Operating profit has grown by an annual rate of 0%

The company has declared Positive results for the last 5 consecutive quarters

With ROE of 16.38%, it has a expensive valuation with a 2.94 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Insurance

Market cap

USD 67,268 Million (Large Cap)

P/E

20.00

Industry P/E

Dividend Yield

253.78%

Debt Equity

-999,999.00

Return on Equity

11.90%

Price to Book

2.37

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2026)

Net Profit:

779 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

24.04%

6 Months

28.0%

1 Year

32.44%

2 Years

42.25%

3 Years

52.34%

4 Years

54.45%

5 Years

61.04%

MetLife, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.59%

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

23.81%

Dividend Payout Ratio

47.69%

Pledged Shares

Institutional Holding

77.77%

ROCE (avg)

ROE (avg)

9.10%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.37

EV to EBIT

EV to EBITDA

EV to Capital Employed

5.49

EV to Sales

0.62

PEG Ratio

Dividend Yield

253.78%

ROCE (Latest)

ROE (Latest)

11.90%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 155 Schemes (33.51%)

Foreign Institutions

Held by 438 Foreign Institutions (16.38%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -32.96% vs 42.40% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "292.00",
          "val2": "265.00",
          "chgp": "10.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "779.00",
          "val2": "1,162.00",
          "chgp": "-32.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "69.30%",
          "val2": "92.90%",
          "chgp": "-2.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -23.42% vs 177.40% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "753.00",
          "val2": "714.00",
          "chgp": "5.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,061.00",
          "val2": "1,037.00",
          "chgp": "2.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,403.00",
          "val2": "4,444.00",
          "chgp": "-23.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "74.20%",
          "val2": "93.80%",
          "chgp": "-1.96%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

0.00

Interest

292.00

265.00

10.19%

Exceptional Items

0.00

Consolidate Net Profit

779.00

1,162.00

-32.96%

Operating Profit Margin (Excl OI)

69.30%

92.90%

-2.36%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -32.96% vs 42.40% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

753.00

714.00

5.46%

Interest

1,061.00

1,037.00

2.31%

Exceptional Items

0.00

Consolidate Net Profit

3,403.00

4,444.00

-23.42%

Operating Profit Margin (Excl OI)

74.20%

93.80%

-1.96%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -23.42% vs 177.40% in Dec 2024

All Annual Results

Company CV

About MetLife, Inc.

MetLife, Inc.

Insurance

MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses. Its Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. Latin America offers products, including life insurance, and retirement and savings products. Life insurance includes universal, variable and term life products. EMEA offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance.

Company Coordinates

Company Details

200 Park Ave , NEW YORK NY : 10166-0005

Tel: 1 212 5785500

https://www.metlife.com/

Registrar Details